We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer Hits Teva With Suit Over Eye Infection Drug

Law360 (April 10, 2006, 12:00 AM EDT) -- German pharmaceutical giant Bayer Healthcare AG has sued generic drug maker Teva Pharmaceuticals USA Inc. in an attempt to thwart a generic version of its blockbuster eye infection drug, Vigamox, from entering the marketplace.

Flanked by exclusive licensee Alcon Laboratories, Bayer accused Teva of violating its intellectual property by trying to produce a generic version of the eye drop solution, according to court papers filed in the U.S. District Court for the District of Delaware.

Of the three patents-in-suit, which date back to 1991, two are...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.